Home › Subarachnoid Hemorrhage › NCT06893588
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
RecruitingObservational study
Prospective, Open-Label, Multi-Center ProceDural Data CollectIon Case Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts (The DILATE Registry)
Who can join
Ages 22 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Age ≥22 2. Symptomatic cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage (aSAH) in the internal carotid artery (ICA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), or basilar artery (BA) 3. Vessel dilation procedure was performed with the NeVa VS 4. Subject or legal representative is able and willing to give informed consent within 3 days (72 hours) post-index procedure Exclusion Criteria: * None
About the study
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
What is being tested
- NEVA VS (device)
Sponsor: Vesalio · Participants: 200 · Started: Apr 14, 2025
Contact the study team
- Sharon Shachar, Graduate · Phone: 2486976616
Official record on ClinicalTrials.gov — NCT06893588
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.